Cover
Vol. 4 No. 1 (2014)

Published: July 31, 2014

Pages: 13-17

Research Article

Role of Fibrillin-3 on Fertilization Capacity in Pregnant and Non Pregnant Women

Saad S. Al-Dujaily 1 Wafaa Mohammed Abed
1Clinical Reproductive Physiology, High Institute for Infertility Diagnosis and Assisted Reproductive Technology, Al-Nahrain University, Baghdad -Iraq
History
  • Received: April 1, 2014
  • Available Online: July 1, 2014

Abstract

Background: Fibrillin- 3 is a recently discovered hormone.However, there are no studies till now regarding the role of fibrillin-3 hormone on fertilization capacity in infertile pregnant and non-pregnant women. Objectives: The goals of this study are concentrated on the fertilization capacity parameters by examining the effect of in vivo concentration of fibrillin-3 hormone on the ovarians status at different menstrual cycle phases and to elucidate the correlation between the levels of this hormone with pregnant and non -pregnant women following Intrauterine insemination (IUI) outcome or through natural pregnancy. Methods: Sixty infertile couples were involved in this prospective study. The couples were divided according to the type of insemination and ovulation induction program into two groups Group(1): Thirty spouses were subjected to induced ovulation stimulation by using clomiphene citrate(CC) and recommended for natural coitus. Group(2): Thirty couples, the females were induced ovulation stimulation by CC, Gonal F-751U /ml and Fostimon 50IU/ml with IUI. Measurements of Fibrillin-3 with other reproductive hormones were done at different phases of menstrual cycle and for pregnant and non-pregnant women following natural coitus and IUI. Results: The mean of fibrillin-3 hormone level at day 2 of menstrual cycle was 3.7ng/ml (ranged from 3.50 to3.91) in the two groups. The mean of fibrillin-3 hormone at cycle day 13 was 6.6ng/ml( ranged from 5.83to 7.0). Whereas, The basal level of Fibrillin-3 at 14 days post insemination was 3.3ng/ml. The range is from 2.76,395 to 3.29 ng/ml. There was no significant difference in the mean of Fibrillin -3hormone between pregnant and non-pregnant women through the phases of menstrual cycle or between the two groups, but there is a significant value between fibrillin-3 post insemination and E2 day 2 and day 13 P<0.05. Conclusion: The present study concluded that Fibrillin -3 hormone has no role in pregnancy, but it may have a main relationship with estrogens reaction in folliculogenesis, oocyte maturation and follicular contents. Therefore, this hormone may be one of the new hormones that interfere with fertilization capacity.

Keywords

References

  1. "World health organization infertility". http://www.who.int/topics/infertility/en.Who.int. 2013-0319.Rerieved 2013-06-17
  2. Cooper TG, Noon E, Von E S, et al. World Health Organization reference values for human semen characteristics". Hum, Reprod, update 2010. 16 (3):23145
  3. Rebar RW. Merck manuals, Unexplained Infertility Last full review/revision November 2008.
  4. Apter D. "Serum steroids and pituitary hormones in female puberty: a partly longitudinal study". Clin. Endocrinol. Oxf. 1980; 12 (2): 107-120.
  5. Lessee B.A. Medical management of endometriosis and infertility: 2000;pp 1089-1096.
  6. Agarwal A, Gupta S and Sharma RK. Role of oxidative stress in female reproduction. Repp Biol Endocrinol. 2005;3:28.
  7. Gougeon A: Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996; 17: 121.
  8. Gregory FE. Follicle growth and development. http://www.glowm.com/resources/glowm Ret. Jun 2013.
  9. Ravindranath N, Little- Ihrig L, et al. Vascular endothelial growth factor mRNA expression in the primate ovary in relation to follicular growth and corpus luteum function. Endocrinology 1992; 2065:254.
  10. Taymor ML. The regulation of follicular growth: some clinical implications in reproductive endocrinology. Fertil Steril 1996; 65:235.
  11. Sabatier L, Miosge N, Hubmacher D, et al. Fibrillin-3 expression in human development. 2010.
  12. Matthews DE, Farewell VT. Using and Understanding medical statistics,(4th ed),2007.
  13. University Hospital & Medical Center at Stony Brook Male Infertility Program "Understanding Semen Analysis".. Retrieved 4 May 2013.
  14. Al-Dujaily SS. And Al-Barazanchi, M. R. In vitro epididymal sperm activation and intra-peritoneal insemination experimental model for azoosoermia obstructive in mice. 4th Asian Symposiums on Animal Biotechnology, Kamiina-Japan. 1998;pp:110-113.
  15. Al-DujailySS, Al-Janabi AS.And nori, M. Effect of Glycyrrhiza extract on in vitro sperm activation of asthenospermic patients. J.Babylon University. 2006;11(3):477-483.
  16. Schlegel PN, Girardi SK. In vitro fertilization for male factor infertility. J Clin Endocrinol Metab 1997;82:709-716.
  17. Baker G, Liu DY, Bourne H. Assessment of the male and preparation of sperm for ARTs. In: Handbook of in vitro fertilization in: Trounson AO, Gardner DK. 2nd edition. CRC Press, USA. 2000:99-126.
  18. Egbuniwe MN, Higdon HI, Boone WR. Building new culture media for assisted reproductive. J.S.Car. Aca. Sci. 2004:2:18-24.
  19. Scott RT. Toner JP. Muasher SJ. et al. Folliclestimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51 (4):651654.
  20. The medical Biochemistry. http: //themedicalbiochemistrypage.org/steroid-hormones.phpSteroid Hormones- The Medical Biochemistry 2013.Page10-2.
  21. Garzo, VG, Dorrington J H. "Aromatase activity in human granulose cells during follicular development and the modulation by follicle-stimulating hormone and insulin" American journal of obstetrics and gynecology 1984;148 (5): 657-662.